Goldman Sachs Initiates Coverage On BrightSpring Health with Buy Rating, Announces Price Target of $71
BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. BTSG | 0.00 |
Goldman Sachs analyst Scott Fidel initiates coverage on BrightSpring Health (NASDAQ:
BTSG) with a Buy rating and announces Price Target of $71.
